Psychiatry and Neurology, Neurology · Brooklyn, NY
NPI
1821161258
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
450 Clarkson Ave # Msc1213
Brooklyn, NY, 11203
Phone (718) 270-2502
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
933 services
Medicare patients, 2024
65
Average age 69
Drug cost, 2024
$2.8M
684 prescriptions
Company payments, 2025
$16K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yaacov Anziska was code 99214 (office e&m - established), 37 times for 23 patients. In total Yaacov Anziska billed 933 services in 26 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 37 | 23 | $96.03 | $3,553 |
| 99232 Hospital E&M - Subsequent | Facility | 23 | 11 | $63.68 | $1,465 |
| 99213 Office E&M - Established | Office | 14 | 13 | $53.44 | $748 |
| 99222 Hospital E&M - Initial | Facility | 14 | 14 | $82.89 | $1,161 |
By year: 2022 $18K for 753 services; 2023 $21K for 493 services; 2024 $16K for 933 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yaacov Anziska prescribed most often to Medicare patients was Gabapentin, with 71 prescriptions and refills. In total Yaacov Anziska wrote 684 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 71 | 83 | 17 | $1,103 |
| Pyridostigmine Bromide Generic | 51 | 93 | 13 | $3,118 |
| Duloxetine Hcl Generic | 40 | 42 | Under 11 | $2,265 |
| Pregabalin Generic | 39 | 39 | Under 11 | $1,759 |
| Budesonide Er Budesonide | 34 | 34 | Under 11 | $126K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 34 | 34 | Under 11 | $297K |
| Baclofen Generic | 28 | 28 | Under 11 | $878 |
| Prednisone Generic | 28 | 58 | Under 11 | $163 |
| Levetiracetam Generic | 25 | 25 | Under 11 | $352 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 17 | 33 | Under 11 | $202 |
| Azathioprine Generic | 16 | 24 | Under 11 | $1,473 |
| Botox Onabotulinumtoxina | 15 | 43 | Under 11 | $32K |
| Evrysdi Risdiplam | 14 | 14 | Under 11 | $368K |
| Nortriptyline Hcl Generic | 14 | 14 | Under 11 | $335 |
| Firdapse Amifampridine Phosphate | 12 | 12 | Under 11 | $342K |
Brand drugs: 210 claims; generic drugs: 474 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yaacov Anziska $16K ($16K in general payments such as food, travel and fees) from 6 companies. The largest payer was Janssen Scientific Affairs, LLC with $7,580.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.